4//SEC Filing
REESE ALBERT L JR 4
Accession 0001348362-25-000004
CIK 0001348362other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:30 PM ET
Size
12.9 KB
Accession
0001348362-25-000004
Insider Transaction Report
Form 4
REESE ALBERT L JR
Director
Transactions
- Award
Stock Options
2025-05-15+11,000→ 43,000 totalExercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (11,000 underlying)
Holdings
- 3,400
Stock Options
Exercise: $3.00From: 2021-02-01Exp: 2026-02-01→ Common Shares (3,400 underlying) - 6,800
Stock Options
Exercise: $3.39From: 2022-03-08Exp: 2027-03-08→ Common Shares (3,400 underlying) - 10,000
Stock Options
Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (3,200 underlying) - 15,000
Stock Options
Exercise: $0.87From: 2023-07-25Exp: 2028-07-25→ Common Shares (5,000 underlying) - 20,000
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (5,000 underlying) - 32,000
Stock Options
Exercise: $3.39From: 2024-07-26Exp: 2029-07-26→ Common Shares (12,000 underlying) - 10,917
common shares
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001244736
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:30 PM ET
- Size
- 12.9 KB